Shanghai Ming Ju Biotechnology Co., Ltd.
Quick facts
Marketed products
- Relma-cel · Oncology
Relma-cel is a CAR-T cell therapy that redirects patient T cells to recognize and eliminate cancer cells expressing a specific tumor antigen.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: